Cellulose Derivative Excipient - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The cellulose derivative excipient market size was valued at USD 2.17 billion in 2025 and is estimated to grow from USD 2.38 billion in 2026 to USD 3.68 billion by 2031, at a CAGR of 9.13% during the forecast period (2026-2031). This report is segmented by Product Type (Microcrystalline Cellulose, Hypromellose, Hydroxypropyl Cellulose, and More), Function (Binders, Film-Coating Agents, and More), End-User Industry (Pharmaceutical, Food and Beverages, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Cellulose Derivative Excipient Market Trends and Insights

Expansion of Oral Solid Dosage Manufacturing Pulls Through Cellulose Demand

Tablets remain the dominant finished dosage form, and direct compression is gaining share over wet granulation in 2025. This method relies heavily on high-performance Microcrystalline Cellulose (MCC) and co-processed cellulose excipients, as material flow and compaction consistency directly affect tablet production. Generic drug production in India and China is particularly important to the cellulose derivative excipient market, as it broadens the customer base for these materials and increases demand for qualified grades. Oral solid dosage investments are increasingly located near excipient production, shortening lead times and reducing supply chain costs for integrated manufacturers. This location pattern also gives buyers a clearer connection between planned tableting capacity and future requirements for binders, fillers, disintegrants, and coating materials. Hovione completed a EUR 40 million (USD 46.40 million) expansion at its Loures tablet manufacturing center in August 2026, adding 25% more commercial-scale batch tableting capacity and strengthening demand for high-grade MCC and Hydroxypropyl Methylcellulose (HPMC) binders.

Adoption of Modified-Release and Controlled-Release Formulations

Hypromellose (HPMC) is widely used as a matrix-forming polymer in hydrophilic controlled-release tablets. Its pharmacopeia listings in the United States, Europe, and Japan provide a familiar regulatory route for formulation teams, particularly when a drug product requires a recognized excipient. HPMC swells in gastrointestinal fluid, forming a gel barrier that controls diffusion and matrix erosion. Formulators can select viscosity grades ranging from K4M to K100M to tailor release profiles from 4 to 24 hours, providing flexibility for chronic-disease products where dose regularity matters. FDA guidance on nitrosamine drug substance-related impurities has increased reformulation work on marketed controlled-release products, including decisions involving lower-nitrite-risk excipient grades. Ethyl cellulose and cellulose acetate broaden the material set by providing diffusion-barrier coatings for multiparticulate modified-release systems.

Raw-Material Supply and Price Volatility

Pharmaceutical-grade wood pulp and cotton linters are the primary cellulose feedstocks, and their availability does not follow pharmaceutical demand cycles. Forestry cycles, crop failures, logistics disruptions, and currency fluctuations can affect delivered material costs and influence procurement decisions across the cellulose derivative excipient market. Supply concentration means that a single plant outage can affect multiple downstream cellulose categories simultaneously. Propylene oxide adds a petrochemical cost layer for hydroxypropyl cellulose and HPMC production, exposing some grades to both pulp and refinery market conditions. Buyers are increasingly using multi-year supply agreements to limit exposure, but smaller formulators can still face spot-price pressure. This can reduce margins, limit inventory flexibility, and delay product launches when suitable materials are not readily available.

Other drivers and restraints analyzed in the detailed report include:

• Rising Demand for Direct-Compression and Continuous Manufacturing Grades
• Shift Toward Renewable and Biodegradable Excipients
• Nitrite and Nitrosamine Risk in Excipients

Segment Analysis

Microcrystalline cellulose held 42.56% of the cellulose derivative excipient market share in 2025. Its roles as a binder, disintegrant, and filler support its use in direct-compression and wet-granulation tablet formulations. MCC delivers compressibility and tabletability performance at an industrial scale. Its plastic deformation behavior helps maintain tablet integrity across different compression speeds. This performance supports specification continuity among large generic manufacturers in India, China, and Southeast Asia.

Hypromellose was the second-largest product type, used in controlled-release tablet matrices and film-coating systems. Its listings in the USP, European Pharmacopeia 11, and Japanese Pharmacopeia support regulatory confidence in product filings. Carboxymethyl cellulose (CMC) and methyl cellulose are used primarily as suspending agents and stabilizers in liquid and semi-solid dosage forms. Ethyl cellulose provides hydrophobic diffusion barriers in multiparticulate sustained-release systems. Hydroxypropyl cellulose is the fastest-growing product type, with the cellulose derivative excipient market size for this category projected to grow at a 9.86% CAGR from 2026 through 2031. In March 2025, Shin-Etsu announced a JPY 10 billion (USD 0.06 billion) investment in its SE Tylose facility in Germany and its Naoetsu Plant in Japan to support the production of low-substituted hydroxypropyl cellulose (L-HPC) for tablet disintegration and strength enhancement. A 2026 study also reported carboxylated cellulose nanocrystals achieving tablet hardness above 29 N and disintegration times near 3 seconds.

Complete Report Scope:

• By Product Type
  • Microcrystalline Cellulose
  • Hypromellose
  • Hydroxypropyl Cellulose
  • Carboxymethyl Cellulose
  • Methyl Cellulose
  • Ethyl Cellulose
  • Other Cellulose Derivatives
• By Function
  • Binders
  • Film-Coating Agents
  • Stabilizers and Suspending Agents
  • Bio-Adhesives
  • Gelling Agents
  • Others
• By End-User Industry
  • Pharmaceutical
  • Food and Beverages
  • Cosmetic and Personal Care
  • Others
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific held 33.48% of the cellulose derivative excipient market share in 2025 and is forecast to grow at a 10.05% CAGR through 2031. The region combines oral solid dosage manufacturing capacity with pharmaceutical raw-material processing. China is a regional producer and consumer of cellulose derivatives. Its position as a major exporter means that production and pricing decisions can affect supply conditions in other markets. India plays a different role, with growing domestic capacity aimed at reducing reliance on imported polymer excipients.

North America is a mature demand center led by the United States. The region is characterized by high excipient prices, rigorous supplier qualification periods of 6-18 months, and a shift from batch processes to continuous direct compression. These changes increase the need for consistent microcrystalline cellulose (MCC) and co-processed cellulose grades. Canada and Mexico are primarily downstream generic-drug markets that follow U.S. pharmacopeia standards. Mexico's growing contract development and manufacturing organization (CDMO) activity supports demand for mid-tier excipient grades. Europe's demand base is shaped by European Medicines Agency (EMA) quality requirements and growing interest in renewable-feedstock variants and plant-based tablet-coating systems.

South America has a smaller but notable role in the cellulose derivative excipient market. Brazil is the leading regional demand center, and Argentina supports regular consumption for generic oral solid dosage products. The Middle East and Africa represent the smallest regional groupings in the cellulose derivative excipient market. Saudi Arabia is a demand driver, driven by its domestic pharmaceutical manufacturing ambitions. South Africa functions as both a consumer and a small-scale regional production base for generic drug excipients. Both regions may see demand increase as CDMOs establish production closer to cost-sensitive emerging markets and require internationally approved cellulose grades.

List of Companies Covered in this Report:

• Asahi Kasei Corporation
• Ashland
• Blanver Farmoquímica Ltda.
• Colorcon Inc.
• Daicel Corporation
• DFE Pharma
• Dow
• Eastman Chemical Company
• International Flavors & Fragrances Inc.
• J. RETTENMAIER & SÖHNE GmbH + Co KG
• Mingtai Chemical Co., Ltd.
• Nippon Soda Co., Ltd.
• Roquette Frères
• Shin-Etsu Chemical Co., Ltd.
• Sigachi Industries

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support